Efficacy and safety of tofacitinib for immune-mediated inflammatory rheumatic diseases (Part I)
Deciphering the mechanisms of the pathogenesis of immune-mediated inflammatory rheumatic diseases (IIRDs) and designing a wide range of biological agents (BAs) are the major achievements of 21st century medicine. A new promising area of pharmacotherapy for IIRDs is associated with the design of so-c...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Russo |
| Έκδοση: |
IMA PRESS LLC
2020-02-01
|
| Σειρά: | Научно-практическая ревматология |
| Θέματα: | |
| Διαθέσιμο Online: | https://rsp.mediar-press.net/rsp/article/view/2845 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|